Skip to main content
Top
Published in: Archives of Virology 12/2009

01-12-2009 | Original Article

The VP5 protein of infectious bursal disease virus promotes virion release from infected cells and is not involved in cell death

Authors: Yongping Wu, Lianlian Hong, Juxiu Ye, Zhenyu Huang, Jiyong Zhou

Published in: Archives of Virology | Issue 12/2009

Login to get access

Abstract

The VP5 protein of infectious bursal disease virus (IBDV) was shown in previous reports to be involved in the cytopathogenicity of IBDV. Here, using a rescued VP5-deficient IBDV infectious clone, it was demonstrated that a lack of VP5 expression significantly hinders the release of viral progeny from infected cells but does not block intracellular virus production. Monoclonal VP5-expressing Vero cells did not exhibit induction of cell death. Using VP5-specific mAbs generated in our laboratory as a tool, it was shown by flow cytometry analysis that VP5 was detectable on the surface of IBDV-infected and monoclonal VP5-expressing Vero cells and bursal cells in IBDV-infected chickens. Taken together, these data suggest that the VP5 protein is involved in regulation of the release of intracellular IBDV virions and may be used as a cell-surface marker for detecting IBDV-infected cells in FCM analysis. This study contributes to the further characterization of the VP5 protein, which will allow a better understanding of the mechanism of IBDV pathogenicity.
Literature
1.
go back to reference Azad AA, Barrett SA, Fahey KJ (1985) The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious bursal disease virus. Virology 143:35–44CrossRefPubMed Azad AA, Barrett SA, Fahey KJ (1985) The characterization and molecular cloning of the double-stranded RNA genome of an Australian strain of infectious bursal disease virus. Virology 143:35–44CrossRefPubMed
2.
go back to reference Bottcher B, Kiselev NA, Stel’Mashchuk VY, Perevozchikova NA, Borisov AV, Crowther RA (1997) Three-dimensional structure of infectious bursal disease virus determined by electron cryomicroscopy. J Virol 71:325–330PubMed Bottcher B, Kiselev NA, Stel’Mashchuk VY, Perevozchikova NA, Borisov AV, Crowther RA (1997) Three-dimensional structure of infectious bursal disease virus determined by electron cryomicroscopy. J Virol 71:325–330PubMed
3.
go back to reference Dobos P, Hill BJ, Hallett R, Kells DT, Becht H, Teninges D (1979) Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J Virol 32:593–605PubMed Dobos P, Hill BJ, Hallett R, Kells DT, Becht H, Teninges D (1979) Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J Virol 32:593–605PubMed
4.
go back to reference Hudson PJ, McKern NM, Power BE, Azad AA (1986) Genomic structure of the large RNA segment of infectious bursal disease virus. Nucleic Acids Res 14:5001–5012CrossRefPubMed Hudson PJ, McKern NM, Power BE, Azad AA (1986) Genomic structure of the large RNA segment of infectious bursal disease virus. Nucleic Acids Res 14:5001–5012CrossRefPubMed
5.
go back to reference Ismail NM, Saif YM, Moorhead PD (1988) Lack of pathogenicity of five serotype 2 infectious bursal disease viruses in chickens. Avian Dis 32:757–759CrossRefPubMed Ismail NM, Saif YM, Moorhead PD (1988) Lack of pathogenicity of five serotype 2 infectious bursal disease viruses in chickens. Avian Dis 32:757–759CrossRefPubMed
6.
go back to reference Ismail NM, Saif YM (1991) Immunogenicity of infectious bursal disease viruses in chickens. Avian Dis 35:460–469CrossRefPubMed Ismail NM, Saif YM (1991) Immunogenicity of infectious bursal disease viruses in chickens. Avian Dis 35:460–469CrossRefPubMed
7.
go back to reference Jackwood DH, Saif YM (1987) Antigenic diversity of infectious bursal disease viruses. Avian Dis 31:766–770CrossRefPubMed Jackwood DH, Saif YM (1987) Antigenic diversity of infectious bursal disease viruses. Avian Dis 31:766–770CrossRefPubMed
8.
go back to reference Kaerber G (1931) Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmakol 162:480–483CrossRef Kaerber G (1931) Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch Exp Pathol Pharmakol 162:480–483CrossRef
9.
go back to reference Kibenge FS, Dhillon AS, Russell RG (1988) Biochemistry and immunology of infectious bursal disease virus. J Gen Virol 69(Pt 8):1757–1775CrossRefPubMed Kibenge FS, Dhillon AS, Russell RG (1988) Biochemistry and immunology of infectious bursal disease virus. J Gen Virol 69(Pt 8):1757–1775CrossRefPubMed
10.
go back to reference Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497CrossRefPubMed Kohler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495–497CrossRefPubMed
11.
go back to reference Lombardo E, Maraver A, Espinosa I, Fernandez-Arias A, Rodriguez JF (2000) VP5, the nonstructural polypeptide of infectious bursal disease virus, accumulates within the host plasma membrane and induces cell lysis. Virology 277:345–357CrossRefPubMed Lombardo E, Maraver A, Espinosa I, Fernandez-Arias A, Rodriguez JF (2000) VP5, the nonstructural polypeptide of infectious bursal disease virus, accumulates within the host plasma membrane and induces cell lysis. Virology 277:345–357CrossRefPubMed
12.
go back to reference McFerran JB, McNulty MS, McKillop ER, Connor TJ, McCracken RM, Collins DS, Allan GM (1980) Isolation and serological studies with infectious bursal disease viruses from fowl, turkeys and ducks: demonstration of a second serotype. Avian Pathol 9:395–404CrossRefPubMed McFerran JB, McNulty MS, McKillop ER, Connor TJ, McCracken RM, Collins DS, Allan GM (1980) Isolation and serological studies with infectious bursal disease viruses from fowl, turkeys and ducks: demonstration of a second serotype. Avian Pathol 9:395–404CrossRefPubMed
13.
go back to reference Muller H, Scholtissek C, Becht H (1979) The genome of infectious bursal disease virus consists of two segments of double-stranded RNA. J Virol 31:584–589PubMed Muller H, Scholtissek C, Becht H (1979) The genome of infectious bursal disease virus consists of two segments of double-stranded RNA. J Virol 31:584–589PubMed
14.
go back to reference Muller H, Becht H (1982) Biosynthesis of virus-specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious virus and incomplete particles. J Virol 44:384–392PubMed Muller H, Becht H (1982) Biosynthesis of virus-specific proteins in cells infected with infectious bursal disease virus and their significance as structural elements for infectious virus and incomplete particles. J Virol 44:384–392PubMed
15.
go back to reference Mundt E, Vakharia VN (1996) Synthetic transcripts of double-stranded Birnavirus genome are infectious. Proc Natl Acad Sci USA 93:11131–11136CrossRefPubMed Mundt E, Vakharia VN (1996) Synthetic transcripts of double-stranded Birnavirus genome are infectious. Proc Natl Acad Sci USA 93:11131–11136CrossRefPubMed
16.
go back to reference Mundt E, Kollner B, Kretzschmar D (1997) VP5 of infectious bursal disease virus is not essential for viral replication in cell culture. J Virol 71:5647–5651PubMed Mundt E, Kollner B, Kretzschmar D (1997) VP5 of infectious bursal disease virus is not essential for viral replication in cell culture. J Virol 71:5647–5651PubMed
17.
go back to reference Sambrook J, Russell DW (2001) Southern blotting and northern hybridization. Cold Spring Harbor Laboratory Press, New York Sambrook J, Russell DW (2001) Southern blotting and northern hybridization. Cold Spring Harbor Laboratory Press, New York
18.
go back to reference Schroder A, van Loon AA, Goovaerts D, Teifke JP, Mundt E (2001) VP5 and the N terminus of VP2 are not responsible for the different pathotype of serotype I and II infectious bursal disease virus. J Gen Virol 82:159–169PubMed Schroder A, van Loon AA, Goovaerts D, Teifke JP, Mundt E (2001) VP5 and the N terminus of VP2 are not responsible for the different pathotype of serotype I and II infectious bursal disease virus. J Gen Virol 82:159–169PubMed
19.
go back to reference Shai Y (1995) Molecular recognition between membrane-spanning polypeptides. Trends Biochem Sci 20:460–464CrossRefPubMed Shai Y (1995) Molecular recognition between membrane-spanning polypeptides. Trends Biochem Sci 20:460–464CrossRefPubMed
20.
go back to reference Tacken MG, Van Den Beuken PA, Peeters BP, Thomas AA, Rottier PJ, Boot HJ (2003) Homotypic interactions of the infectious bursal disease virus proteins VP3, pVP2, VP4, and VP5: mapping of the interacting domains. Virology 312:306–319CrossRefPubMed Tacken MG, Van Den Beuken PA, Peeters BP, Thomas AA, Rottier PJ, Boot HJ (2003) Homotypic interactions of the infectious bursal disease virus proteins VP3, pVP2, VP4, and VP5: mapping of the interacting domains. Virology 312:306–319CrossRefPubMed
21.
go back to reference Teng QY, Zhou JY, Wu JJ, Guo JQ, Shen HG (2006) Characterization of chicken interleukin 2 receptor alpha chain, a homolog to mammalian CD25. FEBS Lett 580:4274–4281CrossRefPubMed Teng QY, Zhou JY, Wu JJ, Guo JQ, Shen HG (2006) Characterization of chicken interleukin 2 receptor alpha chain, a homolog to mammalian CD25. FEBS Lett 580:4274–4281CrossRefPubMed
22.
go back to reference Van Den Berg TP (2000) Acute infectious bursal disease in poultry: a review. Avian Pathol 29:175–194CrossRefPubMed Van Den Berg TP (2000) Acute infectious bursal disease in poultry: a review. Avian Pathol 29:175–194CrossRefPubMed
23.
go back to reference Wang YZ, Wu XP, Li HB, Wu YP, Shi LX, Zheng XJ, Luo M, Yan Y, Zhou JY (2009) Antibody to VP4 protein is an indicator discriminating pathogenic and nonpathogenic IBDV infection. Mol Immunol 46:1964–1969CrossRefPubMed Wang YZ, Wu XP, Li HB, Wu YP, Shi LX, Zheng XJ, Luo M, Yan Y, Zhou JY (2009) Antibody to VP4 protein is an indicator discriminating pathogenic and nonpathogenic IBDV infection. Mol Immunol 46:1964–1969CrossRefPubMed
25.
go back to reference Yao K, Goodwin MA, Vakharia VN (1998) Generation of a mutant infectious bursal disease virus that does not cause bursal lesions. J Virol 72:2647–2654PubMed Yao K, Goodwin MA, Vakharia VN (1998) Generation of a mutant infectious bursal disease virus that does not cause bursal lesions. J Virol 72:2647–2654PubMed
26.
go back to reference Yao K, Vakharia VN (2001) Induction of apoptosis in vitro by the 17-kDa nonstructural protein of infectious bursal disease virus: possible role in viral pathogenesis. Virology 285:50–58CrossRefPubMed Yao K, Vakharia VN (2001) Induction of apoptosis in vitro by the 17-kDa nonstructural protein of infectious bursal disease virus: possible role in viral pathogenesis. Virology 285:50–58CrossRefPubMed
27.
go back to reference Zheng X, Hong L, Li Y, Guo J, Zhang G, Zhou J (2006) In vitro expression and monoclonal antibody of RNA-dependent RNA polymerase for infectious bursal disease virus. DNA Cell Biol 25:646–653CrossRefPubMed Zheng X, Hong L, Li Y, Guo J, Zhang G, Zhou J (2006) In vitro expression and monoclonal antibody of RNA-dependent RNA polymerase for infectious bursal disease virus. DNA Cell Biol 25:646–653CrossRefPubMed
28.
go back to reference Zheng X, Hong L, Shi L, Guo J, Sun Z, Zhou J (2008) Proteomics analysis of host cells infected with infectious bursal disease virus. Mol Cell Proteomics 7:612–625PubMed Zheng X, Hong L, Shi L, Guo J, Sun Z, Zhou J (2008) Proteomics analysis of host cells infected with infectious bursal disease virus. Mol Cell Proteomics 7:612–625PubMed
29.
go back to reference Zhou JY, Wu JX, Cheng LQ, Zheng XJ, Gong H, Shang SB, Zhou EM (2003) Expression of immunogenic S1 glycoprotein of infectious bronchitis virus in transgenic potatoes. J Virol 77:9090–9093CrossRefPubMed Zhou JY, Wu JX, Cheng LQ, Zheng XJ, Gong H, Shang SB, Zhou EM (2003) Expression of immunogenic S1 glycoprotein of infectious bronchitis virus in transgenic potatoes. J Virol 77:9090–9093CrossRefPubMed
30.
go back to reference Zhou JY, Cheng LQ, Zheng XJ, Wu JX, Shang SB, Wang JY, Chen JG (2004) Generation of the transgenic potato expressing full-length spike protein of infectious bronchitis virus. J Biotechnol 111:121–130CrossRefPubMed Zhou JY, Cheng LQ, Zheng XJ, Wu JX, Shang SB, Wang JY, Chen JG (2004) Generation of the transgenic potato expressing full-length spike protein of infectious bronchitis virus. J Biotechnol 111:121–130CrossRefPubMed
31.
go back to reference Zhou JY, Wang JY, Chen JG, Wu JX, Gong H, Teng QY, Guo JQ, Shen HG (2005) Cloning, in vitro expression and bioactivity of duck interleukin-2. Mol Immunol 42:589–598CrossRefPubMed Zhou JY, Wang JY, Chen JG, Wu JX, Gong H, Teng QY, Guo JQ, Shen HG (2005) Cloning, in vitro expression and bioactivity of duck interleukin-2. Mol Immunol 42:589–598CrossRefPubMed
32.
go back to reference Zhou JY, Ye JX, Ye WC, Chen QX, Zheng XJ, Guo JQ (2005) Antigenic and molecular characterization of infectious bursal disease virus in China. Prog BiochemBiophys 32:37–45 Zhou JY, Ye JX, Ye WC, Chen QX, Zheng XJ, Guo JQ (2005) Antigenic and molecular characterization of infectious bursal disease virus in China. Prog BiochemBiophys 32:37–45
Metadata
Title
The VP5 protein of infectious bursal disease virus promotes virion release from infected cells and is not involved in cell death
Authors
Yongping Wu
Lianlian Hong
Juxiu Ye
Zhenyu Huang
Jiyong Zhou
Publication date
01-12-2009
Publisher
Springer Vienna
Published in
Archives of Virology / Issue 12/2009
Print ISSN: 0304-8608
Electronic ISSN: 1432-8798
DOI
https://doi.org/10.1007/s00705-009-0524-4

Other articles of this Issue 12/2009

Archives of Virology 12/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine